Nerve growth factor (NGF) in inflammation and asthma;Le facteur de croissance des nerfs (NGF) dans l'inflammation et l'asthme

Revue des Maladies Respiratoires

Volumn 21, Issue 2 PART 1, 2004, Pages 328-342

  Freund, V ^b   Frossard, N ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b NONE

Author keywords

Airways; Asthma; Bronchi; Inflammation; Neurotrophins; NGF (nerve growth factor)

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN;

AIRWAY; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CELL INFILTRATION; EPITHELIUM CELL; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LUNG FIBROBLAST; LUNG LAVAGE; NERVE GROWTH; REVIEW; SENSORY NERVE; SMOOTH MUSCLE FIBER;

EID: 3042728455     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8425(04)71290-5     Document Type: Review

References (186)

1. Levi-Montalcini R: The nerve growth factor 35 years later. Science 1987; 237: 1154-62.
2. Levi Montalcini R, Dal Toso R, Della Valle F, Skaper SD, Leon A: Update of the NGF saga. J Neuro Sci 1995; 130: 119-27.
3. Dechant G, Neumann H: Neurotrophins. Adv Exp Med Biol 2002; 513: 303-34.
4. Lindsay RM, Thoenen H, Barde YA: Placode and neural crest-derived sensory neurons are responsive at early developmental stages to brain-derived neurotrophic factor. Dev Biol 1985; 112: 319-28.
5. Barde YA, Davies AM, Johnson JE, Lindsay RM, Thoenen H: Brain derived neurotrophic factor. Prog Brain Res 1987; 71: 185-9.
6. Hohn A, Leibrock J, Bailey K, Barde YA: Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 1990; 344: 339-41.
7. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, Yancopoulos GD: Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990; 247: 1446-51.
8. Hallbook F, Ibanez CF, Persson H: Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991; 6: 845-58.
9. Ip NY, Ibanez CF, Nye SH, McClain J, Jones PF, Gies DR, Belluscio L, Le Beau MM, Espinosa R 3rd, Squinto SP, et al.: Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci USA 1992; 89: 3060-4.
10. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A: Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 1991; 7: 857-66.
11. Berkemeier LR, Ozcelik T, Francke U, Rosenthal A: Human chromosome 19 contains the neurotrophin-5 gene locus and three related genes that may encode novel acidic neurotrophins. Somat Cell Mol Genet 1992; 18: 233-45.
12. Gotz R, Koster R, Winkler C, Raulf F, Lottspeich F, Schartl M, Thoenen H: Neurotrophin-6 is a new member of the nerve growth factor family. Nature 1994; 372: 266-9.
13. Gärtner A, Shostak Y, Hackel N, Ethell I, Thoenen H: Ultrastructural identification of storage compartments and localization of activity-dependent secretion of neurotrophin-6 in hippocampal neurons. Mol Cell Neurosci 2000; 15: 215-34.
14. Du JJ, Dou KF, Peng SY, Qian BZ, Xiao HS, Liu F, Wang WZ, Guan WX, Gao ZQ, Liu YB, Han ZG: Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study. World J Gastroenerol 2003; 9: 1431-4.
15. Levi-Montalcini R, Angeletti PU: Second symposium on catecholamines. Modification of sympathetic function. Immunosympathectomy. Pharmacol Rev 1966; 18: 619-28.
16. Thoenen H, Brandtlow C, Heumann R: The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem 1987; 109: 145-78.
17. Bax B, Blaber M, Ferguson G, Sternberg MJ, Walls PH: Prediction of the three-dimensional structures of the nerve growth factor and epidermal growth factor binding proteins (kallikreins) and an hypothetical structure of the high molecular weight complex of epidermal growth factor with its binding protein. Protein Sci 1993; 2: 1229-41.
18. Fahnestock M: Structure and biosynthesis of nerve growth factor. Curr Top Microbiol Immunol 1991; 165: 1-26.
19. Ibanez C: Emerging themes in structural biology of neurotrophic factors. Trends Neurosci 1998; 21: 438-44.
20. McDonald NQ, Lapatto R, Murray-Rust J, Gunning J, Wlodawer A, Blundell T: New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature 1991; 354: 411-4.
21. Francke U, de Martinvilie B, Coussens L, Ullrich A: The human gene for the beta subunit of nerve growth factor is located on the proximal short arm of chromosome 1. Science 1983; 222: 1248-51.
22. Chao MV: Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003; 4: 299-309.
23. Gotz R, Schartl M: The conservation of neurotrophic factors during vertebrate evolution. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 1994; 108: 1-10.
24. Ullrich A, Gray A, Berman C, Dull TJ: Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature 1983; 303: 821-5.
25. Patapoutian A, Reichardt LF: Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 2001; 11: 272-80.
26. Chao MV: The p75 neurotrophin receptor. J Neurobiol 1994; 25: 1373-85.
27. Lee R, Kermani P, Teng KK, Hempstead BL: Regulation of cell survival by secreted proneurotrophins. Science 2001; 294: 1945-8.
28. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, Longo FM, Bresnahan JC, Hempstead BL, Yoon SO: ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 2002; 36: 375-86.
29. Ibanez CF: Jekyll-Hyde neurotrophins: the story of proNGF. Trends Neurosci 2002; 25: 284-6.
30. Martin-Zanca D, Hughes SH, Barbacid M: A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 1986; 319: 743-8.
31. Wiesmann C, Ultsch MH, Bass SH, de Vos AM: Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999; 401: 184-8.
32. Muragaki Y, Timothy N, Leight S, Hempstead BL, Chao MV, Trojanowski JQ, Lee VM: Expression of trk receptors in the developing and adult human central and peripheral nervous system. J Comp Neurol 1995; 356: 387-97.
33. Aloe L, Bracci-Laudiero L, Bonini S, Manni L: The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allerg 1997; 52: 883-94.
34. Bonini S, Lambiase A, Lapucci G, Properzi F, Bresciani M, Bracci-Laudiero ML, Mancini MJ, Procoli A, Micera A, Sacerdoti G, Bonini S, Levi-Schaffer F, Rasi G, Aloe L: Nerve growth factor and asthma. Allergy 2002; 57: Suppl 72: 13-5.
35. Kaplan DR, Martin-Zanca D, Parada LF: Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced byNGF. Nature 1991; 350: 158-60.
36. Obermeier A, Halfter H, Wiesmuller KH, Jung G, Schlessinger J, Ullrich A: Tyrosine 785 is a major determinant of Trk-substrate interaction. EMBO J 1993a; 12: 933-41.
37. Obermeier A, Lammers R, Wiesmuller K, Jung G, Schlessinger J, Ullrich A: Identification of Trk binding sites for SHC and phosphatidylinositol 3′-kinase and formation of a multimeric signaling complex. J Biol Chem 1993b; 268: 22963-6.
38. York RD, Molliver DC, Grewal SS, Stenberg PE, McCleskey EW, Stork PJ: Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol Cell Biol 2000; 20: 8069-83.
39. Wu C, Lai CF, Mobley W: Nerve growth factor activates persistent Rap1 signaling in endosomes. J Neurosci 2001; 21: 5406-16.
40. Kaplan DR, Miller FD: Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 1997; 9: 213-21.
41. Huebner K, Isobe M, Chao M, Bothwell M, Ross AH, Finan J, Hoxie JA, Sehgal A, Buck CR, Lanahan A, et al.: The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias. Proc Natl Acad Sci USA 1986; 83: 1403-7.
42. Chapman BS, Kuntz ID: Modeled structure of the 75-kDa neurotrophin receptor. Protein Sci 1995; 4: 1696-707.
43. Chao MV, Hempstead BL: p75 and Trk: a two-receptor system. Trends Neurosci 1995; 18: 321-6.
44. Johnson D, Lanahan A, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell M, Chao M: Expression and structure of the human NGF receptor. Cell 1986; 47: 545-54.
45. Roux PP, Barker PA: Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 2002; 67: 203-33.
46. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhauser N, Bohm-Matthaei R, Baeuerle PA, Barde YA: Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 1996; 272: 542-5.
47. Ye X, Mehlen P, Rabizadeh S, VanArsdale T, Zhang H, Shin H, Wang JJ, Leo E, Zapata J, Hauser CA, Reed JC, Bredesen DE: TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J biol Chem 1999; 274: 30202-8.
48. Mamidipudi V, Li X, Wooten MW: Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa B. J Biol Chem 2002; 277: 28010-8.
49. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA: Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994; 265: 1596-9.
50. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV: Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996; 383: 716-9.
51. Hempstead BL, Salzer JL: Neurobiology. A glial spin on neurotrophins. Science 2002; 298: 1184-6.
52. Khursigara G, Bertin J, Yano H, Moffett H, DiStefano PS, Chao MV: A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J Neurosci 2001; 21: 5854-63.
53. DeFreitas MF, McQuillen PS, Shatz CJ: A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons. J Neurosci 2001; 21: 5121-9.
54. Chao M, Casaccia-Bonnefil P, Carter B, Chittka A, Kong H, Yoon SO: Neurotrophin receptors: mediators of life and death. Brain Res Rev 1998; 26: 295-301.
55. Yano H, Chao MV: Neurotrophin receptor structure and interactions. Pharm Acta Helv 2000; 74: 253-60.
56. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV: High-affinity NGF binding requires coexpression of the trk protooncogene and the low-affinity NGF receptor. Nature 1991; 350: 678-83.
57. Benedetti M, Levi A, Chao MV: Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci USA 1993; 90: 7859-63.
58. Bibel M, Hoppe E, Barde Y: Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J 1999; 18: 616-22.
59. Arevalo JC, Conde B, Hempstead BL, Chao MV, Martin-Zanca D, Perez P: TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol Cell Biol 2000; 20: 5908-16.
60. Esposito D, Patel P, Stephens RM, Perez P, Chao MV, Kaplan DR, Hempstead BL: The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem 2001; 276: 32687-95.
61. Lad SP, Peterson DA, Bradshaw RA, Neet KE: Individual and Combined Effects of TrkA and p75NTR Nerve Growth Factor Receptors: a role for the high affinity receptor site. J Biol Chem 2003; 278: 24808-17.
62. Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U: Expression of functional trk protooncogen in human monocytes. Proc Natl Acad Sci USA 1993; 90: 5423-7.
63. Santambrogio L, Benedetti M, Chao MV, Muzaffar R, Kulig K, Gabellini N, Hochwald G: Nerve growth factor production by lymphocytes. J Immunol 1994; 153: 4488-95.
64. Torcia M, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, Rubartelli A, Cozzolino F, Aloe L, Garaci E: Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996; 85: 345-56.
65. Lambiase A, Bracci-Laudiero L, Bonini S, Bonini S, Starace G, D'Elios MM, De Carli M, Aloe L: Human CD4+ T cell clones produce and release nerve growth factor and express high affinity nerve growth factor receptors. J Allergy Clin Immunol 1997; 100: 408-14.
66. Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe, L, Levi-Montalcini R: Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 3739-43.
67. Nilsson G, Forsberg-Nilsson K, Xiang Z, Hallbààk F, Nilsson K, Metcalfe DD: Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997; 27: 2295-301.
68. Solomon A, Aloe L, Pe'er J, Frucht-Pery J, Bonini S, Bonini S, Levi-Schaffer F: Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 1998; 102: 454-60.
69. Kobayashi H, Gleich GJ, Butterfield JH, Kita H: Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002; 99: 2214-20.
70. Ricci A, Greco S, Mariotta S, Felici L, Amenta F, Bronzetti E: Neurotrophin and neurotrophin receptor expression in alveolar macrophages: an immunocytochemical study. Growth Factors 2000; 18: 193-202.
71. Barouch R, Appel E, Kazimirsky G, Brodie C: Macrophages express neurotrophins and neurotrophin receptors. Regulation of nitric oxide production by NT-3. J Neuroimmunol 2001; 112: 72-7.
72. Kelly C, Ward C, Stenton CS, Bird G, Hendrick DJ, Walters EH: Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. Thorax 1998; 43: 684-92.
73. Olgart-Höglund C, Frossard N: Nerve growth factor and asthma. Pulm Pharm Ther 2002; 15: 51-60.
74. Olgart-Höglund C, De Blay F, Oster JP, Duvernelle C, Kassel O, Pauli G, Frossard N: Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 2002; 20: 1110-6.
75. Fox AJ, Patel HJ, Barnes PJ, Belvisi MG: Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases. Eur J Pharmacol 2001; 424: 159-62.
76. Pons F, Freund V, Kuissu H, Mathieu E, Olgart C, Frossard N: Nerve growth factor secretion by human lung epithelial A549 cells in pro- and anti-inflammatory conditions. Eur J Pharmacol 2001; 428: 365-9.
77. Olgart C, Frossard N: Human lung fibroblasts secrete nerve growth factor. Effect of inflammatory cytokines and glucocorticoids. Eur Respir J 2001; 18: 115-21.
78. Freund V, Pons F, Joly V, Mathieu E, Martinet N, Frossard N: Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions. Eur Respir J 2002; 20: 458-63.
79. Murase K, Murakami Y, Takayanagi K, Furukawa Y, Hayashi K: Human fibroblast cells synthezise and secrete nerve growth factor in culture. Biochem Biophys Res Commun 1992; 184: 373-9.
80. Varilek GW, Neil GA, Bishop WP, Lin J, Panttazis NJ: Nerve growth factor synthesis by intestinal epithelial cells. Am J Physiol 1995; 269: G445-52.
81. Ishida K, Yoshimura N, Yoshida M, Honda Y, Murase K, Hayashi K: Expression of neurotrophic factors in cultured human retinal pigment epithelial cells. J Biochem 1997; 16: 96-101.
82. Ueyama T, Hamada M, Hano T, Nishio I, Masuyama Y, Furukawa S: Production of nerve growth factor by cultured vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 1993; 11: 1061-5.
83. Donovan MJ, Miranda RC, Kraemer R, Mc Caffrey TA, Tessarollo L, Mahadeo D, Sharif S, Kaplan DR, Tsoulfas P, Parada L: Neurorrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol 1995; 147: 309-24.
84. Nemoto K, Fukamachi K, Nemoto F, Miyara S, Hamada M, Nakamura Y, Senba E, Ueyama T: Gene expression of neurotrophins and their receptors in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1998; 245: 284-8.
85. Tanner R, Chambers P, Khadra MH, Gillepsie JL: The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU 2000; 85: 1115-9.
86. Grewe M, Vogelsgang K, Ruzicka T, Stege H, Krutmann J: Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 2000; 114: 1108-12.
87. Kassel O, De Blay F, Duvernelle C, Olgart C, Israel-Biet D, Krieger P, Moreau L, Muller C, Pauli G, Frossard N: Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 2001; 31: 1432-40.
88. Braun A, Appel E, Baruch R, Herz U, Botchkarev V, Paus R, Brodie C, Renz H: Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998; 28: 3240-51.
89. Nassenstein C, Braun A, Erpenbeck VJ, Lommatzsch M, Schmidt S, Krug N, Luttmann W, Renz H, Virchow JC Jr: The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic broncbial asthma. J Exp Med 2003; 198: 455-67.
90. Di Marco E, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, De Luca M: Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulate their growth by a novel autocrine loop. J Biol Chem 1993; 268: 22838-46.
91. Micera A, Vigneti E, Pickholtz D, Reich R, Pao O, Bonini S, Maquart FX, Aloe L, Levi-Schaffer F: Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001; 98: 6162-7.
92. Hattori A, Iwazaki S, Murase K, Tsujimoto M, Sato M, Hayashi K, Kihono M: Tumor necrosis factor is markedly synergistic with interleukin-1 and interferon gamma in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994; 340: 177-80.
93. Brodie C, Goldreich N, Haiman T, Kazimirsky G: Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J Neuroimmunol 1998; 81: 20-30.
94. Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ: Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995; 115: 1265-75.
95. Virchow JC, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A: Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998; 158: 2002-5.
96. Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P: Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999; 159: 487-94.
97. Lindholm D, Hengerer B, Heumann R, Carroll P, Thoenen, H: Glucocorticoid hormones negatively regulate nerve growth factor expression in vivo and in cultured rat fibroblasts. Eur J Neurosci 1990; 2: 795-801.
98. Hoyle GW, Graham RM, Finkelstein JH, Nguyen KP, Gozal D, Friedman M: Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol 1998; 18: 149-57.
99. Verge VM, Richardson PM, Benoit R, Riopelle RJ: Histochemical characterization of sensory neurones with high-affinity receptors for nerve growth factor. J Neurocytol 1989; 18: 583-91.
100. Lee KF, Li E, Huber J, Landis SC, Sharpe AH, Chao MV, Jaenisch R: Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 1992; 69: 737-49.
101. Schatteman GC, Langer T, Lanahan AA, Bothwell MA: Distribution of the 75-kD low-affinity nerve growth factor receptor in the primate peripheral nervous system. Somatosens Mol Res 1993; 10: 415-32.
102. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M: Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 1994; 368: 246-9.
103. Lindsay RM, Harmar AJ: Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurones. Nature 1989; 337: 362-4.
104. Donnerer J, Schuligoi R, Stein C: Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992; 49: 693-8.
105. Vedder H, Affolter HU, Otten U: Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurones during early postnatal development. Neuropeptides 1993; 24: 351-7.
106. Hunter DD, Myers AC, Undem BJ: Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am J Respir Crit Care Med 2000; 161: 1985-90.
107. Tam SY, Tsai M, Yamaguchi M, Yano K, Butterfield JH, Galli SJ: Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cells. Blood 1997; 90: 1807-20.
108. Burgi B, Otten UH, Ochensberger B, Rihs S, Heese K, Ehrhard PB, Ibanez CF, Dahinden CA: Basophil priming by neurotrophic factors: activation through the trk receptor. J Immunol 1996; 157: 5582-8.
109. Kawamoto K, Okada T, Kannan Y, Ushio H, Matsumoto M, Matsuda H: Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood 1995; 86: 4638-44.
110. Franklin RA, Brodie C, Melamed I, Terada N, Lucas JJ, Gelfand EW: Nerve growth factor induces activation of MAP-kinase and p90rsk in human B lymphocytes. J Immunol 1995; 154: 4965-72.
111. Melamed I, Kelleher CA, Franklin RA, Hempstead B, Kaplan D, Gelfand EW: Nerve growth factor signal transduction in B lymphocytes is mediated by gp140trk. Eur J Immunol 1996; 26: 1985-92.
112. Melamed I, Patel H, Brodie C, Gelfand EW: Activation of Vav and Ras through the nerve growth factor and B cell receptors by different kinases. Cell Immunol 1999; 191: 83-9.
113. Welker P, Grabbe J, Grutzkau A, Henz BM: Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature mast cells (HMC-1). Immunology 1998; 94: 310-7.
114. Aloe L, Levi-Montalcini R: Mast cell increase in tissues in neo-natal rats injected with the nerve growth factor. Brain Res 1977; 133: 358-63.
115. Böhm A, Aloe L, Levi-Montalcini R: Nerve growth factor enhances precocious differentiation and numerical increase in mast cells in culture of rat splenocytes. Accad Naz Lincei 1986; 80: 1-6.
116. Aloe L, De Simone R: NGF primed spleen cells injected in brain of developing rats differentiate into mast cells. Int. J Dev Neurosci 1989; 7: 565-73.
117. Matsuda H, Kannan Y, Ushio H, Kiso Y, Kanemoto T, Suzuki H, Kitamura Y: Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991; 174: 7-14.
118. Horigome K, Bullock ED, Johnson EM: Effects of nerve growth factor on rat peritoneal mast cells: survival promotion and immediate-early gene induction. J Biol Chem 1994; 269: 2695-702.
119. Bullock ED, Johnson EM: Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion. J Biol Chem 1996; 271: 27500-8.
120. Kanbe N, Kurosawa M, Miyachi Y, Kanbe M, Saitoh H, Matsuda H: Nerve growth factor prevents apoptosis of cord blood-derived human cultured mast cells synergistically with stem cell factor. Clin Exp Allergy 2000; 30: 1113-20.
121. Thorpe LW, Perez-Polo JR: The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res 1987; 18: 134-9.
122. Otten U, Ehrhard P, Peck R: Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989; 86: 10059-63.
123. Brodie C, Gelfand EW: Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J Immunol 1992; 148: 3492-7.
124. Kronfeld I, Kazimirsky G, Gelfand EW, Brodie C: NGF rescues human B lymphocytes from anti-IgM induced apoptosis by activation of PKCzeta. Eur J Immunol 2002; 32: 136-43.
125. Hamada A, Watanabe N, Ohtomo H, Matsuda H: Nerve growth factor enhances survival and cytotoxic activity of human eosinophils. Br J Haematol 1996; 93: 299-302.
126. La Sala A, Corinti S, Federici M, Saragovi HU, Girolomoni G: Ligand activation of nerve growth factor receptor TrkA protects monocyres from apoptosis. J Leukoc Biol 2000; 68: 104-10.
127. Bruni A, Bigon E, Boarato E, Mietto L, Leon A, Toffano G: Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett 1982; 138: 190-2.
128. Sugiyama K, Suzuki Y, Furuta H: Histamine-release induced by 7S nerve growth factor of mouse submandibular salivary glands. Arch Oral Biol 1985; 30: 93-5.
129. Pearce FL, Thompson HL: Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 1986; 372: 379-93.
130. Murakami M, Tada K, Nakajima K, Kudo I: Cyclooxygenase-2-dependent prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2. J Immunol 1997; 159: 439-6.
131. Tal M, Liberman R: Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci Lett 1997; 22: 129-32.
132. Kawamoto K, Aoki J, Tanaka A, Itakura A, Hosono H, Arai H, Kiso Y, Matsuda H: Nerve growth factor activates mast cells through the collaborative interaction with lysophosphatidylserine expressed on the membrane surface of activated platelets. J Immunol 2002; 168: 6412-9.
133. Kannan Y, Ushio H, Koyama H, Okada M, Oikawa M, Yoshihara T, Kaneko M, Matsuda H: 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood 1991; 77: 1320-5.
134. Matsuda H, Switzer J, Coughlin MD, Bienenstock J, Denburg JA: Human basophilic cell differentiation promoted by 2.5S nerve growth factor. Int Arch Allergy Appl Immunol 1988; 86: 453-7.
135. Bischoff S, Dahinden CA: Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992; 79: 2662-9.
136. Heinemann A, Ofner M, Amann R, Paskar BA: A novel assay to measure the calcium flux in human basophils: effects of chemokines and nerve growth factor. Pharmacology 2003; 67: 49-54.
137. Susaki Y, Shimizu S, Katakura K, Watanabe N, Matsumoto M, Tsudzuki M, Furusaka T, Kitamura Y, Matsuda H: Functional properties of murine macrophages promoted by nerve growth factor. Blood 1996; 88: 4630-7.
138. Kimata H, Yoshida A, Ishioka C, Kusunoki T, Hosoi S, Mikawa H: Nerve growth factor specifically induces human IgG4 production. Eur J Immunol 1991; 21: 137-41.
139. Gee AP, Boyle MDP, Munger KL, Lawman MJP, Young M: Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci USA 1983; 80: 7215-8.
140. Boyle MDP, Lawman MJP, Gee AP, Young M: Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 1985; 134: 564-8.
141. Kohyama T, Liu X, Wen FQ, Kobayashi T, Abe S, Ertl R, Rennard SI: Nerve growth factor stimulates fibronectin-induced fibroblast migration. J Lab Clin Med 2002; 140: 329-35.
142. Ching TV, Parry EM, Hope-Gill BDM, Parry JM, Harrison NK: The neurotrophin nerve growth factor stimulates human lung fibroblast proliferation in vitro. Am J Respir Crit Care Med 2003; 167: A463 (abstract).
143. Kraemer R, Nguyen H, March KL, Hempstead B: NGF activates similar intracellular signaling pathways in vascular smooth muscle cells as PDGF-BB but elicits different biological responses. Arterioscler Thromb Vasc Biol 1998; 19: 1041-50.
144. Raychaudhuri SK, Raychaudhuri SP, Weltman H, Farber E: Effect of nerve growth factor and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 2001; 293: 291-5.
145. Cantarella G, Lempereur L, Presta M, Ribarti D, Lombardo G, Lazarovici P, Zappala G, Pafumi C, Bernardini R: Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 2002; 16: 1307-9.
146. Freund V, Diop L, Bertrand C, Frossard N: Neurotrophin receptors involved in the NGF-induced proliferation of airway smooth muscle cells. Am J Respir Crit Care Med 2003; 167: A30 (abstract).
147. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L: Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996; 93: 10955-60.
148. Undem BJ, Hunter DD, Liu M, Haak-Fredscho M, Oakragly A, Fischer A: Allergen-induced sensory neuroplasticity in airways. Int Arch Allergy Immunol 1999; 118: 150-3.
149. Sanico AM, Stanisz AM, Gleeson TD, Bora S, Proud D, Bienenstock J, Koliatsos VE, Togias A: Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am J Respir Crit Care Med 2000; 161: 1631-5.
150. Friberg SG, Olgart C, Gustafsson LE: Nerve growth factor increases airway responsiveness and decreases levels of exhaled nitric oxide during histamine challenge in an in vivo guinea pig model. Acta Physiol Scand 2001; 173: 239-45.
151. De Vries A, Dessing MC, Engels F, Henricks PAJ, Nijkamp FP: Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999; 159: 1541-4.
152. De Vries A, Van Rijnsoever C, Engels F, Henricks PA, Nijkamp FP: The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea pigs. Br J Pharmacol 2001; 134: 771-6.
153. De Vries A, Engels F, Henricks PA, Leusink-Muis T, Fischer A, Nijkamp FP: Antibodies directed against nerve growth factor inhibit the acute bronchiconstriction due to allergen challenge in guinea-pigs. Clin Exp Allergy 2002; 32: 325-8.
154. Tokuoka S, Takahashi Y, Masuda T, Tanaka H, Furukawa S, Nagai H: Disruption of antigen-induced airway inflammation and airway hyperresponsiveness in low affinity neurotrophin receptor p75 gene deficient mice. Br J Pharmacol 2001; 134: 1580-6.
155. Lewin GR, Ritter AM, Mendell LM: NGF induced hyperalgesia in the neonatal and adult. J Neurosci 1993; 13: 2136-48.
156. Lewin GR, Rueff A, Mendell LM: Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 1994; 6: 1903-12.
157. McMahon SB: NGF as a mediator of pain. Philos Trans R Soc Lond B Biol Sci 1996; 351: 431-40.
158. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A: Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996; 19: 514-20.
159. Woolf CJ, Safieh-Garabedian B, Ma QP, Ctilly P, Winter J: Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 1994; 62: 327-31.
160. Woolf CJ, Ma QP, Allchorne A, Poole S: Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 1996; 16: 2716-23.
161. Kerzel S, Path G, Nockher WA, Quarcoo D, Raap U, Groneberg DA, Dinh QT, Fisher A, Braun A, Renz H: Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am J Respir Cell Mol Biol 2003; 28: 170-8.
162. Renz H: Neurorrophins in bronchial asthma. Respir Res 2001; 2: 265-8.
163. Renz H: The role of neurotrophins in bronchial asthma. Eur J Pharmacol 2001; 429: 231-7.
164. Jacoby DB: Airway neural plasticity. Am J Respir Cell Mol Biol 2003; 28: 138-41.
165. Snapper CM, Finkelman FD, Paul WE: Differential regulation of IgG1 and IgE synthesis by interleukin-4. J Exp Med 1988; 167: 183-96.
166. Path G, Braun A, Meents N, Kerzel S, Quarcoo D, Raap U, Hoyle GW, Nockher WA, Renz H: Augmentation of allergic early-phase reaction by nerve growth factor. Am J Respir Crit Care Med 2002; 166: 818-26.
167. Chiappara G, Gagliardo R, Siena A, Bonsignore MR, Bousquer J, Bonsignore G, Vignola AM: Airway remodelling in the pathogenesis of asthma. Curr Opin Allergy Clin Immunol 2001; 1: 85-93.
168. Wilson JW, Bamford TL: Assessing the evidence for remodelling of the airway in asthma. Pulm Pharmacol Ther 2001; 14: 229-47.
169. Roche WR, Beasley R, Williams JH, Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1: 520-4.
170. Wilson JW, Li X: The measurement of teticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997; 27: 363-71.
171. Carroll NG, Cooke C, James AL: Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med 1997; 155: 689-95.
172. Li X, Wilson JW: Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156: 229-33.
173. Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ: Substance P immunoreactive nerves in airways from asthmatics and non asthmatics. Eur Respir J 1991; 4: 673-82.
174. Brown RH, Zerhouni EA, Mitzner W: Airway edema potentiates airway reactivity. J Appl Physiol 1995; 79: 1242-8.
175. Ebina M, Takahashi T, Chiba T, Motomiya M: Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993; 148: 720-6.
176. Stewart AG: Airway wall remodelling and hyperresponsiveness: modelling remodelling in vitro and in vivo. Pulm Pharmacol Ther 2001; 14: 255-65.
177. Cosgaya JM, Aranda A: Nerve growth factor regulates transforming growth factor-beta 1 gene expression by both transcriptional and posttranscriptional mechanisms in PC12 cells. J Neurochem 1995; 65: 2484-90.
178. Chevet E, Lemaitre G, Janjic N, Barritault D, Bikfalvi A, Katinka MD: Fibroblast growth factor receptors participate in the control of mitogen-activated protein kinase activity during nerve growth factor-induced neuronal differentiation of PC12 cells. J Biol Chem 1999; 274: 20901-8.
179. Noga O, Englmann C, Hanf G, Grutzkau A, Guhl S, Kungel G: Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clin Exp Allergy 2002; 32: 1348-54.
180. Sin AZ, Roche EM, Togias A, Lichtenstein LM, Schroeder JT: Nerve growth factor or IL-3 induces more IL-13 production from basophils of allergic subjects than from basophils of nonallergic subjects. J Allerg Clin Immunol 2001; 108: 387-93.
181. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L: Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998; 338: 1174-80.
182. Lambiase A, Bonini S, Aloe L, Rama P, Bonini S: Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stroma melting. Arch Ophtalmol 2000; 118: 1446-9.
183. Nithya M, Suguna L, Rose C: The effect of nerve growth factor on the early responses during the process of wound healing. Biochim Biophys Acta 2003; 1620: 25-31.
184. Takahashi H, Uno S, Watanabe Y, Arakawa K, Nakagawa S: Expression of nerve growth factor-induced type 1 plasminogen activator inhibitor (PAI-1) mRNA is inhibited by genistein and wortmannin. Neuroreport 2000; 11: 1111-5.
185. Puxeddu I, Alian A, Micera AM, Piliponsky A, Panet F, Levi-Schaffer F: Nerve growth factor induces sprouting formation in cultures rat aorta rings. Am J Respir Crit Care Med 2003; 160: A342 (Abstract).
186. Calza L, Giardino L, Giuliani A, Aloe L, Levi-Montalcini R: Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci USA 2001; 98: 4160-5.